The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking - Takeaways - MDSpire

The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking

  • By

  • Camille Esneau

  • David Boettiger

  • Sarah Leask

  • Nathan E Bryant

  • Natalie Niessen

  • Jodie McVernon

  • Adrian Marcato

  • Sandra Carlson

  • Stuart Browne

  • Rejoy Thomas

  • Edward C Holmes

  • Krispin Hajkowicz

  • Lynelle Tilbrook

  • Nathan Moon

  • Craig Dalton

  • Nathan W Bartlett

  • Joshua S Davis

  • December 18, 2025

  • 0 min

Share

  • 1

    The study assessed the feasibility of monitoring respiratory virus infections in the community using self-collected nasal swabs.

  • 2

    Participants self-collected weekly nasal swabs over 50 weeks, achieving an 84% collection and return rate.

  • 3

    Rhinovirus and SARS-CoV-2 were the most frequently detected viruses, with 24.2% of positive cases found in asymptomatic individuals.

  • 4

    The integration of self-sampling with the FluTracking platform provides valuable insights into both symptomatic and asymptomatic respiratory infections.

  • 5

    This approach enhances community-based surveillance, capturing a broader spectrum of respiratory virus transmission dynamics.

Original Source(s)

The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking

  • by Camille Esneau, David Boettiger, Sarah Leask, Nathan E Bryant, Natalie Niessen, Jodie McVernon, Adrian Marcato, Sandra Carlson, Stuart Browne, Rejoy Thomas, Edward C Holmes, Krispin Hajkowicz, Lynelle Tilbrook, Nathan Moon, Craig Dalton, Nathan W Bartlett, Joshua S Davis

  • December 18, 2025

Related Content

Ebola at the World Cup? Here’s what we should actually worry about

The latest developments on Ebola, hepatitis B, long Covid

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care